These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34057010)

  • 1. Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes.
    Westerdahl JS; Nusbaum KB; Chung CG; Kaffenberger BH; Ortega-Loayza AG
    J Dermatolog Treat; 2022 Jun; 33(4):2386-2390. PubMed ID: 34057010
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab.
    Low ZM; Mar A
    Australas J Dermatol; 2018 May; 59(2):131-134. PubMed ID: 29205260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyoderma gangrenosum solved by ustekinumab therapy.
    López González J; Lázaro Sáez M; Moreno Moraleda I; Hernández Martínez Á
    Gastroenterol Hepatol; 2021 Apr; 44(4):299-300. PubMed ID: 33069432
    [No Abstract]   [Full Text] [Related]  

  • 4. Ustekinumab in a patient with pyoderma gangrenosum and refractory Crohn's disease.
    García Cámara P; Zubiri Ara ML; García López S
    Med Clin (Barc); 2019 Oct; 153(8):e35-e36. PubMed ID: 30795905
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyoderma Gangrenosum With Ulcerative Colitis Successfully Treated With Ustekinumab.
    Piqueras-García J; Sahuquillo-Torralba AJ; Torres-Navarro I; Botella-Estrada R
    Actas Dermosifiliogr (Engl Ed); 2019 Nov; 110(9):776-778. PubMed ID: 31151671
    [No Abstract]   [Full Text] [Related]  

  • 6. Refractory Pyoderma Gangrenosum in a Patient With Crohn's Disease: Complete Response to Ustekinumab.
    Nunes G; Patita M; Fernandes V
    J Crohns Colitis; 2019 May; 13(6):812-813. PubMed ID: 30535292
    [No Abstract]   [Full Text] [Related]  

  • 7. Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumab.
    Benzaquen M; Monnier J; Beaussault Y; Rouby F; Berbis P
    Australas J Dermatol; 2017 Nov; 58(4):e270-e271. PubMed ID: 28660635
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of refractory pyoderma gangrenosum with ustekinumab only after excision of renal cell carcinoma.
    Cosgarea I; Lovric Z; Körber A; Dissemond J
    Int Wound J; 2016 Oct; 13(5):1041-2. PubMed ID: 25294697
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment with ustekinumab and vacuum-assisted closure therapy in recalcitrant myelodysplastic syndrome-associated pyoderma gangrenosum: case report and literature review.
    Nieto D; Sendagorta E; Rueda JM; Herranz P
    Clin Exp Dermatol; 2019 Jan; 44(1):116-119. PubMed ID: 29851121
    [No Abstract]   [Full Text] [Related]  

  • 10. Ustekinumab treatment for neutrophilic dermatoses associated with Crohn's disease: A multicenter retrospective study.
    de Risi-Pugliese T; Seksik P; Bouaziz JD; Chasset F; Moguelet P; Gornet JM; Bourrier A; Amiot A; Beaugerie L; Francès C; Guégan S;
    J Am Acad Dermatol; 2019 Mar; 80(3):781-784. PubMed ID: 30003991
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose ustekinumab for the treatment of severe, recalcitrant pyoderma gangrenosum.
    Greb JE; Gottlieb AB; Goldminz AM
    Dermatol Ther; 2016 Nov; 29(6):482-483. PubMed ID: 27502191
    [No Abstract]   [Full Text] [Related]  

  • 12. Recalcitrant pyoderma gangrenosum treated with thalidomide.
    Federman GL; Federman DG
    Mayo Clin Proc; 2000 Aug; 75(8):842-4. PubMed ID: 10943240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyoderma gangrenosum in an infant: A case report and review of the literature.
    Crouse L; McShane D; Morrell DS; Wu EY
    Pediatr Dermatol; 2018 Sep; 35(5):e257-e261. PubMed ID: 29656404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infliximab for a girl with refractory pyoderma gangrenosum].
    Nozawa T; Hara R; Kinoshita J; Sano F; Miyamae T; Imagawa T; Mori M; Hirokado M; Takahashi K; Inayama Y; Yokota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec; 31(6):454-9. PubMed ID: 19122376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome.
    Stichweh DS; Punaro M; Pascual V
    Pediatr Dermatol; 2005; 22(3):262-5. PubMed ID: 15916580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pyoderma gangrenosum with methotrexate.
    Teitel AD
    Cutis; 1996 May; 57(5):326-8. PubMed ID: 8726713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When is recalcitrant pyoderma gangrenosum truly recalcitrant?
    Barnabé C; Hurst L; Alowami S
    J Cutan Med Surg; 2003; 7(5):387-9. PubMed ID: 14758523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recalcitrant pyoderma gangrenosum: treatment with thalidomide.
    Hecker MS; Lebwohl MG
    J Am Acad Dermatol; 1998 Mar; 38(3):490-1. PubMed ID: 9520035
    [No Abstract]   [Full Text] [Related]  

  • 19. Superficial pyoderma gangrenosum responding to treatment with isotretinoin.
    Proudfoot LE; Singh S; Staughton RC
    Br J Dermatol; 2008 Dec; 159(6):1377-8. PubMed ID: 18945309
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab as a treatment for recalcitrant pyoderma gangrenosum.
    Singh M; Andrew SM; Lear JT
    Clin Exp Dermatol; 2004 Mar; 29(2):196-7. PubMed ID: 14987282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.